We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Synthetic Surgical Sealant Prevents Blood Leakage

By HospiMedica staff writers
Posted on 31 May 2001
In a clinical study involving 264 treated sites and 148 patients, sealing with a new synthetic self-polymerizing gel was immediate in 47% of treated sites, compared to 20% with the control, a hemostatic agent. More...
The gel is to be used for sealing around vascular reconstructions and vascular incision lines to prevent the leakage of blood.

Called CoSeal, the gel consists of two synthetic liquids that self-polymerize in seconds at the site of application to form a flexible hydrogel seal. CoSeal does not require a primer coat or extra equipment such as light sources or heat to be activated. The gel is designed for us in minimally invasive surgeries as well as in standard open surgical procedures. Since it is a mechanical barrier to leakage, CoSeal can work in patients with normal or compromised coagulation. Developed by Cohesion Technologies, Inc. (Palo Alto, CA, USA), CoSeal has received the CE Mark from the European Union. The company says CoSeal has the potential to significantly reduce surgery times and minimize complications.

"My initial experience with CoSeal has been excellent, and I believe this product represents a significant advancement in surgical sealing,” said Hazim J. Safi, M.D., chairman of cardiothoracic and vascular surgery, University of Texas-Houston Medical School, and a CoSeal clinical investigator.




Related Links:
Cohesion Technologies

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.